Neogen Chemicals Limited (NSE:NEOGEN)
India flag India · Delayed Price · Currency is INR
1,752.30
-20.10 (-1.13%)
May 11, 2026, 1:50 PM IST

Neogen Chemicals Earnings Call Transcripts

Fiscal Year 2026

  • Q3 25/26

    Q3 FY26 saw 9% revenue growth and margin expansion, though PAT was impacted by transitory costs from the Dahej fire and Neogen Ionics ramp-up. Battery chemical guidance for FY27 remains at INR 400-500 crore, with major capacity expansions and customer approvals on track.

  • Q2 25/26

    Q2 FY 2026 delivered 8% revenue growth and 16% gross profit improvement, but profitability was constrained by higher costs from a plant outage and delayed battery chemical demand. Battery Chemicals revenue guidance was revised down for FY 2026, with strong growth expected from FY 2027 as customer approvals and industry ramp-up materialize.

  • Q1 25/26

    Q1 FY26 saw resilient performance with 4% revenue growth despite Dahej plant outage, strong base business volumes, and initial Neogen Ionics sales. Major CapEx and insurance recovery are on track, with robust long-term outlook and growing global demand for non-China battery materials.

Fiscal Year 2025

  • Q4 24/25

    FY25 saw 13% revenue and 24% EBITDA growth despite a fire incident and global pricing headwinds. Battery chemicals expansion and a JV with Morita position the company for strong growth, with FY26 revenue guidance at INR 750–850 crore and battery segment targeting INR 300 crore.

  • Q3 24/25

    Q3 FY25 saw 22% revenue and 71% EBITDA growth, driven by BuLi Chem ramp-up and strong organic performance. Battery chemicals revenue guidance for FY25 was revised down due to delayed approvals, but FY26 outlook remains robust with major capacity expansions and strong customer engagement.

  • Q2 24/25

    Q2 FY25 saw 20% revenue growth and 33% EBITDA rise, driven by strong organic segment and BuLi Chemicals. Battery chemical revenue for FY25 is guided at INR 50–75 crore, with FY26 expected at INR 400–500 crore. CapEx and capacity expansions are on track.

  • Q1 24/25

    Q1 FY25 saw 9% revenue and 18% profit growth, driven by strong organic performance and battery chemical expansion. Capacity ramp-up and long-term contracts are on track, with positive cash flow and robust demand for non-Chinese supply.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Powered by